GPCR Therapeutics
PrivateLast Round
Private Equity
Jul 2, 2026
Est. Valuation
$53.56M
Total Funding Raised
$108.83M
Company Overview
GPCR Therapeutics is a biopharmaceutical company that develops innovative cancer therapeutics by targeting G protein-coupled receptor (GPCR) heteromers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GPCR Therapeutics Comparables
Compare GPCR Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InterAx Biotech | 83% | |
| Gmax Biopharm | 83% | |
| Domain Therapeutics | 82% | |
GPCR Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jul 2, 2026 | ||||
| Series C Extension | Nov 1, 2023 | ||||
| Series C | Jun 30, 2021 | ||||
| Series C | Apr 30, 2021 | ||||
| Series B | Jul 31, 2019 | ||||
Series A | Sep 30, 2016 |
GPCR Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterVest | Series B, Series C, Series A |
| Kinggo Investment Partners | Series C Extension |
| Smilegate Investment | Series B, Series C |
| Kingo Investment Partners | Series C Extension |
| SUNP Corporation | Series C |
| Company K Partners | Series C, Series A |
| Medytox Venture Investment | Series B, Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 76% MoM.
- Nov 23, 2023
$3.15M round led by Medytox Venture Investment
GPCR Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GPCR Therapeutics's valuation, stock price, and market status.